IOTA Pharmaceuticals


IOTA Pharmaceuticals
Fragment - based Drug Discovery
GBM Drug Bank
Glioma & Glioblastoma
WINDOW on Glioblastoma
About IOTA Pharmaceuticals

Built on drug discovery expertise in the field of pharmacological targets such as the histamine, acetylcholine, chemokine and nuclear hormone receptors, the IOTA Discovery team has extensive experience working in drug discovery projects alongside both international pharma and academic partners.

VU Discovery Studies
Histamine Receptors Nicotinic AChR / AChBPs
Kinases Nuclear Hormone Receptors
Chemokine Receptors